What Researchers Did
Researchers investigated whether hyperbaric oxygen therapy could treat Mycobacterium ulcerans infections in mice, comparing three different daily treatment protocols to an untreated control group.
What They Found
The most effective protocol involved 100% oxygen at 2.5 ATA for 1.25 hours, twice a day. After 25 weeks, this treatment group had only 2 autoamputated feet and 12 deaths among the mice, compared to 18 amputated feet and 24 deaths in the control group. This indicates that hyperbaric oxygenation had a beneficial effect in mice infected with M. ulcerans.
What This Means for Canadian Patients
While Mycobacterium ulcerans infection is primarily a health concern in some tropical countries and not common in Canada, this research suggests HBOT could be a valuable additional treatment. It might help reduce severe outcomes like amputations and deaths for patients suffering from this chronic skin infection, if used alongside other therapies.
Canadian Relevance
No direct Canadian connection identified. The study was not conducted in Canada, did not involve Canadian authors, and Mycobacterium ulcerans infection is not a Health Canada-recognised indication for HBOT.
Study Limitations
This study was conducted on mice, meaning its findings may not directly translate to human patients.